Capabilities

Analytics

Data-Driven Development. Built for Viral Vectors.

Analytical development is at the core of successful viral vector and advanced therapy programs. At ReiThera, Analytics is fully integrated with Process Development, GMP Manufacturing, Quality, and Regulatory Affairs to accelerate development and support regulatory success.

Our teams design, optimize, qualify, and transfer analytical methods for product characterization, comparability, stability studies, and GMP manufacturing. Leveraging flexible analytical platforms, established SOPs, and a broad range of methodologies, we rapidly implement tailored testing strategies that reduce timelines, control costs, and support informed development decisions.

Integrated Analytical Development

Our analytical scientists work closely with Process Development and Manufacturing teams to establish robust analytical strategies aligned with product-specific Critical Quality Attributes (CQAs). We support:

Analytical feasibility studies

Method development and optimization

Method transfer

Method qualification and validation

Reference standard and control strategy development

Product characterization programs

Comparability studies

Process characterization support

Regulatory analytical package preparation

This results in a Quality system that is not only compliant but responsive, collaborative, and built around client success.

Product Characterization Expertise

A comprehensive understanding of product quality is essential to support development, release, GMP manufacturing consistency, and regulatory approval.

Our analytical capabilities support characterization of:

Identity

  • PCR-based identity assays

  • Restriction fragment analysis

  • Sequencing and NGS characterization

  •  Transgene confirmation

  • Protein expression profiling

Potency

  • Vector genome quantification

  • Infectious titer assays

  • Gene expression analysis

  • ELISA-based assays

  • Western Blot characterization

Purity and Product Quality Attributes

  • Vector purity assessment

  • Residual process-related impurities

  • Aggregation and particle analysis

  • Dynamic Light Scattering (DLS)

  • Product integrity evaluation

Physicochemical Properties

  • Appearance

  • pH

  • Osmolality

  • Extractable volume

  • Formulation characterization

Supporting Process Development Through Analytics

Analytics and Process Development operate as a single integrated workflow at ReiThera.

 

Our analytical teams support:

  • Upstream process optimization
  • Downstream purification development
  • Critical Process Parameter (CPP) evaluation
  • Critical Quality Attribute (CQA) assessment
  • Scale-up and technology transfer activities
  • Process characterization studies

By combining analytical insights with process knowledge, we accelerate process understanding and facilitate efficient transfer into GMP manufacturing.

Stability & Lifecycle Management

Analytical support extends beyond manufacturing readiness and continues throughout product lifecycle management.

 

Our capabilities include:

  • Stability-indicating method development
  • ICH-compliant stability protocols
  • Long-term stability studies
  • Accelerated stability studies
  • Freeze-thaw characterization
  • In-use stability assessment
  • Trending and shelf-life evaluation

These studies provide the data required to support regulatory filings and commercial lifecycle management.

Viral Vector Focused Expertise

ReiThera has extensive experience supporting analytical development programs for:

  • Adenoviral vectors
  • AAV vectors
  • MVA vectors
  • HSV-based platforms
  • Genetic vaccines
  • Gene therapy products

Our platform knowledge allows us to leverage established analytical strategies while tailoring development programs to the specific needs of each product.

Why ReiThera Quality is Different

Unlike traditional testing laboratories, ReiThera integrates analytical development directly within its viral vector development and manufacturing ecosystem.

 

This enables:

Faster method development and troubleshooting

Strong alignment between analytics and process development

Deep expertise in viral vector characterization

Seamless transition from development to GMP QC testing

Regulatory-ready analytical packages

Efficient support for global clinical programs

The result is an analytical function designed not only to generate data, but to accelerate development, strengthen process understanding, and support successful regulatory outcomes.

error: Content is protected !!